These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 23719483)

  • 1. Lumican as a novel marker for differential diagnosis of Bowen disease and actinic keratosis.
    Takayama R; Ishiwata T; Ansai S; Yamamoto T; Matsuda Y; Naito Z; Kawana S
    Am J Dermatopathol; 2013 Dec; 35(8):827-32. PubMed ID: 23719483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of lumican in hidroacanthoma simplex and clonal-type seborrheic keratosis as a potent differential diagnostic marker.
    Takayama R; Ansai S; Ishiwata T; Yamamoto T; Matsuda Y; Naito Z; Kawana S
    Am J Dermatopathol; 2014 Aug; 36(8):655-60. PubMed ID: 23656908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atypical intraepidermal keratinocytic lesions falling short of carcinoma in situ (Bowen disease) on routine staining: the utility of p16 immunostaining.
    Ko C; Srisuttiyakorn C
    J Cutan Pathol; 2014 Dec; 41(12):975-7. PubMed ID: 25558038
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunohistochemical staining for p16 is a useful adjunctive test in the diagnosis of Bowen's disease.
    Harvey NT; Leecy T; Wood BA
    Pathology; 2013 Jun; 45(4):402-7. PubMed ID: 23635817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytokeratin 17 immunoexpression in actinic keratosis (bowenoid and nonbowenoid) and in Bowen disease.
    Fernandez-Flores A
    Ann Diagn Pathol; 2016 Feb; 20():1-6. PubMed ID: 26740287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of P27, Ki67 and P53 in squamous cell carcinoma, actinic keratosis and Bowen disease.
    Talghini S; Halimi M; Baybordi H
    Pak J Biol Sci; 2009 Jun; 12(12):929-33. PubMed ID: 19777788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dermoscopy of actinic keratosis, intraepidermal carcinoma and squamous cell carcinoma.
    Zalaudek I; Argenziano G
    Curr Probl Dermatol; 2015; 46():70-6. PubMed ID: 25561209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Not Available].
    Barysch MJ
    Praxis (Bern 1994); 2016 Sep; 105(18):1071-7. PubMed ID: 27606914
    [No Abstract]   [Full Text] [Related]  

  • 9. Data Independent Acquisition Proteomic Analysis Can Discriminate between Actinic Keratosis, Bowen's Disease, and Cutaneous Squamous Cell Carcinoma.
    Azimi A; Yang P; Ali M; Howard V; Mann GJ; Kaufman KL; Fernandez-Penas P
    J Invest Dermatol; 2020 Jan; 140(1):212-222.e11. PubMed ID: 31254517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Suspicious eyelid spots].
    Adenis JP; Izambart C
    J Fr Ophtalmol; 2010 Feb; 33(2):122-4. PubMed ID: 20116885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lumican expression in alpha cells of islets in pancreas and pancreatic cancer cells.
    Ping Lu Y; Ishiwata T; Asano G
    J Pathol; 2002 Mar; 196(3):324-30. PubMed ID: 11857496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p16INK4a expression in actinic keratosis and Bowen's disease.
    Salama ME; Mahmood MN; Qureshi HS; Ma C; Zarbo RJ; Ormsby AH
    Br J Dermatol; 2003 Nov; 149(5):1006-12. PubMed ID: 14632806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of lumican, a small leucine-rich proteoglycan with antitumour activity, in human malignant melanoma.
    Brézillon S; Venteo L; Ramont L; D'Onofrio MF; Perreau C; Pluot M; Maquart FX; Wegrowski Y
    Clin Exp Dermatol; 2007 Jul; 32(4):405-16. PubMed ID: 17490399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Guidelines for the diagnosis and treatment of cutaneous squamous cell carcinoma and precursor lesions. Guidelines].
    Haute Autorité de Santé
    Rev Stomatol Chir Maxillofac; 2010 Sep; 111(4):228-37. PubMed ID: 20691458
    [No Abstract]   [Full Text] [Related]  

  • 15. Precancerous Skin Lesions.
    Ferrándiz C; Malvehy J; Guillén C; Ferrándiz-Pulido C; Fernández-Figueras M
    Actas Dermosifiliogr; 2017; 108(1):31-41. PubMed ID: 27658688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different Immunohistochemical Localization of Fatty Acid Binding Protein 5 in Actinic Keratosis Compared with That in Bowen's Disease: A Retrospective Study.
    Ahn B; Kim CH; Chae YS; Lee JH; Lee Y; Ahn HH; Lee YJ
    Am J Dermatopathol; 2021 May; 43(5):356-361. PubMed ID: 33055535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Small proteoglycans of normal adult human kidney: distinct expression patterns of decorin, biglycan, fibromodulin, and lumican.
    Schaefer L; Gröne HJ; Raslik I; Robenek H; Ugorcakova J; Budny S; Schaefer RM; Kresse H
    Kidney Int; 2000 Oct; 58(4):1557-68. PubMed ID: 11012890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The characteristics of human papillomavirus expression and cell proliferation in actinic keratosis and Bowen's disease of the skin.
    Kvlividze O; Gogiashvili L; Burkadze G
    Georgian Med News; 2006 Jul; (136):108-12. PubMed ID: 16905862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The diagnostic value of p63, p16, and p53 immunohistochemistry in distinguishing seborrheic keratosis, actinic keratosis, and Bowen's disease.
    Nasiri S; Azhari V; Bidari-Zerehpoosh F; Asadi-Kani Z; Talebi A
    Dermatol Ther; 2021 Mar; 34(2):e14817. PubMed ID: 33497503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. P27 and mib1 expression in actinic keratosis, Bowen disease, and squamous cell carcinoma.
    Oh CW; Penneys N
    Am J Dermatopathol; 2004 Feb; 26(1):22-6. PubMed ID: 14726819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.